Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.519NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.519NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.519NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.514NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.514NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.514NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GT.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GT.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GT.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.87NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.87NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.87NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAPNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAPNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAPNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BE.1.4.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BE.1.4.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BE.1.4.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.6.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.6.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.6.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.47.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.47.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.47.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBF.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBF.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBF.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CF.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CF.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CF.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.11NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.11NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DN.3.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DN.3.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DN.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DJ.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DJ.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DJ.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBC.1.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBC.1.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
CM.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
CM.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CM.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BW.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BW.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BW.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.10.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.10.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used